Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection
Authors:
- 2 June 2008
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 22 (13) , 2082-2088
Abstract
Recent examples have demonstrated that the high‐resolution liquid chromatography/mass spectrometry (LC/MS)‐based mass defect filtering (MDF) technique was effective in selectively detecting drug metabolites regardless of their molecular weights or fragmentation patterns. The main objective of the current study was to evaluate the general applicability of MDF for drug metabolite detection in typical biological matrices. Mass defect profiles of commonly used biological matrices including plasma, urine, bile, and feces were obtained using an LTQ FT mass spectrometer and were compared with those of 115 commonly prescribed drugs. The mass defect profiles were presented as two‐dimensional Y‐X plots with the determined mass defects of components on the y‐axis versus the corresponding m/z values on the x‐axis. The mass defect profiles of the matrices appeared to be similar for each type of matrix across species, yet marked differences were apparent between matrices of a given species. The mass defect profiles of components in plasma, bile, and feces showed significant separation from most of the 115 drugs. The mass defect profiles of urine did not show such clean separation from that of the 115 drugs. The results suggest that MDF has a broad applicability for selective detection of drug metabolites in plasma, bile and feces although the selectivity for detecting urinary drug metabolites is not as good as in the other matrices. In addition, the mass defect profiles of the biological matrices allow for prediction of the effectiveness of MDF for certain applications, and for designing specific MDF windows for selective detection of drug metabolites. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- An integrated method for metabolite detection and identification using a linear ion trap/Orbitrap mass spectrometer and multiple data processing techniques: application to indinavir metabolite detectionJournal of Mass Spectrometry, 2007
- Detection and Structural Characterization of Glutathione-Trapped Reactive Metabolites Using Liquid Chromatography−High-Resolution Mass Spectrometry and Mass Defect FilteringAnalytical Chemistry, 2007
- Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry DataDrug Metabolism and Disposition, 2006
- Strategies for characterization of drug metabolites using liquid chromatography–tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approachesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Integration of Knowledge-Based Metabolic Predictions with Liquid Chromatography Data-Dependent Tandem Mass Spectrometry for Drug Metabolism Studies: Application to Studies on the Biotransformation of IndinavirAnalytical Chemistry, 2003
- Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicityRapid Communications in Mass Spectrometry, 2003
- A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analysesJournal of Mass Spectrometry, 2003
- Identification of glucuronide conjugates of ketobemidone and its phase I metabolites in human urine utilizing accurate mass and tandem time‐of‐flight mass spectrometryJournal of Mass Spectrometry, 2002
- Use of electrospray ionization and neutral loss liquid chromatography/tandem mass spectrometry in drug metabolism studiesJournal of Mass Spectrometry, 1995
- Mass spectrometry in the analysis of glutathione conjugatesJournal of Mass Spectrometry, 1993